KITLG and Alzheimer disease: Moreover, the presence of bioactive compounds like gomisin A and schisandrin C in SCF, known for their inhibition of AChE activity, supports SCF’s potential preventive and therapeutic benefits in AD by stimulating the parasympathetic nervous system.